Capricor Therapeutics Inc (CAPR) — Capital Reinvestment Ratio
Latest as of March 2023:
0.11x
Capricor Therapeutics Inc (CAPR) has a Capital Reinvestment Ratio of 0.11x as of March 2023, meaning it reinvests 0% of its operating cash flow ($4.21 Million) in capital expenditures ($453.12K). See Capricor Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.11x
Capex / Operating Cash Flow
Operating Cash Flow
$4.21 Million
USD
Capital Expenditures
$453.12K
USD
Data as of
Mar 2023
Most recent filing
Capricor Therapeutics Inc Capital Reinvestment Ratio (2014–2022)
This chart tracks Capricor Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Capricor Therapeutics Inc (2014–2022)
Year-by-year Capital Reinvestment Ratio for Capricor Therapeutics Inc from 2014 to 2022. For live market cap and broader valuation context, see CAPR market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.68x | $4.92 Million | $3.36 Million | ▲ +251.3% |
| 2014 | 0.19x | $958.56K | $186.43K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow